• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[采用HPLC柱切换技术研究米托蒽醌聚氰基丙烯酸酯纳米粒冻干注射剂的药代动力学]

[Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].

作者信息

Zhang Z R, Liao G T, Ye L M

机构信息

School of Pharmacy, West China University of Medical Sciences, Chengdu.

出版信息

Yao Xue Xue Bao. 1995 Nov;30(11):843-7.

PMID:8712010
Abstract

The drug concentration--time curves of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection (DHAQ-PBCA-NP-FDIn) and mitoxantrone solution injection (DHAQ-SIn) in rabbit blood were determined by HPLC column switching technique, and the difference between the DHAQ-PBCA-NP-FDIn and DHAQ-SIn in vivo was observed. The pharmacokinetic parameters of DHAQ-PBCA-NP-FDIn and DHAQ-SIn were presented by statistical moment. The results showed that the MRT and T1/2 of DHAQ-PBCA-NP-FDIn were 2.15 times longer than that of DHAQ-SIn, and the Vss was 4.81 times bigger than that of DHAQ-SIn. This indicates that DHAQ-PBCA-NP-FDIn has targeting and prolonging effect on the action in vivo.

摘要

采用HPLC柱切换技术测定了米托蒽醌聚氰基丙烯酸酯纳米粒冻干注射剂(DHAQ-PBCA-NP-FDIn)和米托蒽醌溶液注射剂(DHAQ-SIn)在兔血中的药物浓度-时间曲线,观察了DHAQ-PBCA-NP-FDIn与DHAQ-SIn在体内的差异。用统计矩法给出了DHAQ-PBCA-NP-FDIn和DHAQ-SIn的药代动力学参数。结果表明,DHAQ-PBCA-NP-FDIn的平均滞留时间(MRT)和半衰期(T1/2)分别是DHAQ-SIn的2.15倍,稳态分布容积(Vss)是DHAQ-SIn的4.81倍。这表明DHAQ-PBCA-NP-FDIn在体内具有靶向性和作用时间延长的效果。

相似文献

1
[Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].[采用HPLC柱切换技术研究米托蒽醌聚氰基丙烯酸酯纳米粒冻干注射剂的药代动力学]
Yao Xue Xue Bao. 1995 Nov;30(11):843-7.
2
[Study on mitoxantrone polycyanoacrylate nanospheres].
Yao Xue Xue Bao. 1994;29(7):544-9.
3
[Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jan;35(1):68-70.
4
[Studies on lung targeting gelatin microspheres of mitoxantrone].[米托蒽醌肺靶向明胶微球的研究]
Yao Xue Xue Bao. 1995;30(7):549-55.
5
[Study on the mitoxantrone carboxymethyl starch microspheres for hepatic artery chemoembolization].
Yao Xue Xue Bao. 1998 Oct;33(10):772-7.
6
[Study on the mitoxantrone ethylcellulose microspheres for liver artery embolization].
Yao Xue Xue Bao. 1996;31(8):626-31.
7
[The pharmacokinetic study on cytarabine nanoparticle lyophilization injection in rabbits].[阿糖胞苷纳米粒冻干注射剂在兔体内的药代动力学研究]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jan;37(1):145-7.
8
[Study on mitoxantrone albumin microspheres for liver targeting].
Yao Xue Xue Bao. 1997;32(1):72-8.
9
A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物-聚乙二醇-甲氧基纳米粒作为静脉内载体的初步研究
J Biomed Mater Res A. 2008 Nov;87(2):515-23. doi: 10.1002/jbm.a.31784.
10
[Study on the pharmacokinetics of the liver targeted mitoxantrone polylactic acid extended-release nanoparticles in rabbits].[米托蒽醌聚乳酸缓释纳米粒在家兔体内的肝脏靶向药代动力学研究]
Hua Xi Yi Ke Da Xue Xue Bao. 1999 Sep;30(3):337-9.